These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11305320)

  • 21. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
    Viard-Leveugle I; Veyrenc S; French LE; Brambilla C; Brambilla E
    J Pathol; 2003 Oct; 201(2):268-77. PubMed ID: 14517844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Signaling and transcriptional control of Fas ligand gene expression.
    Kavurma MM; Khachigian LM
    Cell Death Differ; 2003 Jan; 10(1):36-44. PubMed ID: 12655294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defective death receptor signaling as a cause of tumor immune escape.
    French LE; Tschopp J
    Semin Cancer Biol; 2002 Feb; 12(1):51-5. PubMed ID: 11926412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The human melanoma cell line MelJuSo secretes bioactive FasL and APO2L/TRAIL on the surface of microvesicles. Possible contribution to tumor counterattack.
    Martínez-Lorenzo MJ; Anel A; Alava MA; Piñeiro A; Naval J; Lasierra P; Larrad L
    Exp Cell Res; 2004 May; 295(2):315-29. PubMed ID: 15093732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiproliferative activity of aucubin is through cell cycle arrest and apoptosis in human non-small cell lung cancer A549 cells.
    Hung JY; Yang CJ; Tsai YM; Huang HW; Huang MS
    Clin Exp Pharmacol Physiol; 2008 Sep; 35(9):995-1001. PubMed ID: 18430063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wilms' tumor gene WT1-shRNA as a potent apoptosis-inducing agent for solid tumors.
    Tatsumi N; Oji Y; Tsuji N; Tsuda A; Higashio M; Aoyagi S; Fukuda I; Ito K; Nakamura J; Takashima S; Kitamura Y; Miyai S; Jomgeow T; Li Z; Shirakata T; Nishida S; Tsuboi A; Oka Y; Sugiyama H
    Int J Oncol; 2008 Mar; 32(3):701-11. PubMed ID: 18292948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Signaling through death receptors in cancer therapy.
    Fulda S; Debatin KM
    Curr Opin Pharmacol; 2004 Aug; 4(4):327-32. PubMed ID: 15251124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Critical roles for JNK, c-Jun, and Fas/FasL-Signaling in vitamin E analog-induced apoptosis in human prostate cancer cells.
    Jia L; Yu W; Wang P; Li J; Sanders BG; Kline K
    Prostate; 2008 Mar; 68(4):427-41. PubMed ID: 18196534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcium, cell death, and tumor promotion.
    Trump BF; Berezesky IK
    Prog Clin Biol Res; 1995; 391():121-31. PubMed ID: 8532711
    [No Abstract]   [Full Text] [Related]  

  • 30. Protein kinase C: implications for cancer prevention and treatment.
    Weinstein IB
    Mt Sinai J Med; 1992 Oct; 59(5):387-90. PubMed ID: 1435832
    [No Abstract]   [Full Text] [Related]  

  • 31. [Apoptosis or programmed cell death].
    Feldmann G
    Ann Pathol; 1995; 15(2):92-109. PubMed ID: 7755811
    [No Abstract]   [Full Text] [Related]  

  • 32. CD95 in cancer: tool or target?
    Martin-Villalba A; Llorens-Bobadilla E; Wollny D
    Trends Mol Med; 2013 Jun; 19(6):329-35. PubMed ID: 23540716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploiting death receptor signaling pathways for tumor therapy.
    Fulda S; Debatin KM
    Biochim Biophys Acta; 2004 Dec; 1705(1):27-41. PubMed ID: 15585171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Striving to improve outcomes in oncology: unmet expectations in a complex disease.
    Bates SE
    Clin Cancer Res; 2010 Dec; 16(24):5950. PubMed ID: 21169246
    [No Abstract]   [Full Text] [Related]  

  • 35. What's new in surgical oncology.
    Norton JA
    J Am Coll Surg; 1996 Feb; 182(2):122-9. PubMed ID: 8564043
    [No Abstract]   [Full Text] [Related]  

  • 36. [The state of oncology at the end of the 20th century. Results--unknowns--perspectives].
    García García G
    An R Acad Nac Med (Madr); 1993; 110(3):377-86. PubMed ID: 8116868
    [No Abstract]   [Full Text] [Related]  

  • 37. [Oncology 2003: new therapeutic perspectives].
    Bizzari JP
    Med Sci (Paris); 2003 Feb; 19(2):131. PubMed ID: 12836600
    [No Abstract]   [Full Text] [Related]  

  • 38. [Endocrinology. Integrative bond and cell-to cell-communication].
    Scriba PC; Gärtner R
    Dtsch Med Wochenschr; 1999 Dec; 124(51-52):1544-5. PubMed ID: 10664651
    [No Abstract]   [Full Text] [Related]  

  • 39. [Circulating tumor cells: pitfalls and new promises in clinical oncology].
    Hofman P
    Ann Pathol; 2009 Nov; 29 Spec No 1():S25-7. PubMed ID: 19887244
    [No Abstract]   [Full Text] [Related]  

  • 40. Microsatellite instability. Shifting concepts in tumorigenesis.
    Brentnall TA
    Am J Pathol; 1995 Sep; 147(3):561-3. PubMed ID: 7677169
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.